Segment Reporting (Selected Financial Information by Reporting Segment) (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2017 USD ($) segment	Mar. 31, 2016 USD ($)	Dec. 31, 2016 USD ($)
Segment Reporting Information [Line Items]
Number of Reportable Segments | segment	2
Net revenues:
Net Revenue	$ 56,670	$ 59,366
Gross Profit:
Gross Profit	22,828	24,902
Operating expenses	21,424	20,827
Income from operations	1,404	4,075
Non-operating income (expenses)	100	(259)
Income before income taxes	1,504	3,816
Finished Pharmaceutical Products
Net revenues:
Net Revenue	55,934	58,554
Gross Profit:
Gross Profit	24,310	25,824
Epinephrine
Segment Reporting Information [Line Items]
Net revenues recognized			$ 18,600
Cost of revenues			$ 3,300
API
Net revenues:
Net Revenue	736	812
Gross Profit:
Gross Profit	$ (1,482)	$ (922)